{"database": "lobbying", "table": "lobbying_activities", "rows": [[2507137, "c91fc14d-5ada-445c-8190-c8e1b856018c", "Q3", "KOUNTOUPES DENHAM CARR & REID, LLC", 320918, "CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)", 2020, "third_quarter", "PHA", "Issues related to drug pricing in the pharmaceutical supply chain.  Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Issues related to the implementation of PL 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicare and Medicaid provisions.  Issues related to H.R. 6800, the Heroes Act.  Issues related to proposals that would address drug shortages and national stockpile issues.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-10-13T17:38:01.273000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2507137"], "units": {}, "query_ms": 0.5975801032036543, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}